Workflow
伊利、蒙牛“血战”婴配粉市场:各自商誉减值超30亿元丨乳业变局
2 1 Shi Ji Jing Ji Bao Dao·2025-05-16 13:02

Core Insights - Yili and Mengniu are transitioning away from high growth models, facing significant goodwill impairments from past acquisitions, particularly in the infant formula market [1][3][4] Financial Performance - In 2024, Yili reported revenue of 115.78 billion yuan, a year-on-year decline of 8.24%, and a net profit of 8.453 billion yuan, down 18.94%, primarily due to a 3.037 billion yuan impact from goodwill impairment related to Aoyou [1][6] - Mengniu's revenue for 2024 was 88.675 billion yuan, a decrease of 10.1%, with a net profit of 105 million yuan, a staggering drop of 97.8%, largely due to a 3.9814 billion yuan impact from goodwill impairment related to Bellamy [1][5] Market Trends - The focus of goodwill impairments for both companies is centered on the infant formula market, which has been experiencing a downturn since 2022 [3][4] - The infant formula market is facing challenges, with offline sales down 9.8% and sales volume down 9.4% in 2024, indicating a shift towards a saturated market [5][10] Strategic Moves - Yili's acquisition of Aoyou and Mengniu's acquisition of Bellamy were strategic moves aimed at entering the high-end infant formula market, despite the declining market conditions [3][5] - Both companies are now focusing on high-margin products, with Yili's milk powder and dairy products achieving a gross margin of 41.02% in 2024, compared to lower margins in liquid milk and ice cream [8][11] Future Outlook - Yili and Mengniu are adjusting their strategies to improve profitability, with Yili aiming for a diversified product portfolio and Mengniu targeting revenue growth by 2025 [22][23] - The competition in the infant formula market is expected to intensify as companies strive for profitability amidst a shrinking market [24][25]